Aricept donepezil transdermal patch regulatory update

FDA accepted for review an NDA from Eisai for a transdermal patch formulation of Aricept donepezil to treat Alzheimer's disease (AD). The PDUFA date is April 30, 2011. Eisai has rights from Teikoku Se...